When does FILANA THERAPEUTICS INC (FLNA) report earnings?
FILANA THERAPEUTICS INC (FLNA) will report earnings on 2026-05-06.
FILANA THERAPEUTICS INC (FLNA) Forecast, Price Target & Analyst Ratings
NASDAQ:FLNA • US14817C1071
Current stock price
1.61 USD
+0.02 (+1.26%)
At close:
1.63 USD
+0.02 (+1.24%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FILANA THERAPEUTICS INC (FLNA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.32
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.61 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
FLNA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FLNA.
In the previous month the buy percentage consensus was at a similar level.
FLNA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.32
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 34.13%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
FLNA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | -14.2M | -14.86M -4.65% | -11.85M 20.26% | -6.56M 44.64% | -4.86M 25.91% | -6.8M -39.92% | -32.37M -376.03% | -78.72M -143.19% | -104.427M -32.66% | -140.314M -34.37% | -94.454M 32.68% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -14.2M | -14.96M -5.35% | -11.95M 20.12% | -6.66M 44.27% | -4.96M 25.53% | -6.8M -37.10% | -32.87M -383.38% | -80.02M -143.44% | -105.957M -32.41% | -141.446M -33.49% | -95.39M 32.56% | N/A 23.55% | N/A 94.41% | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.38 4.76% | N/A 18.57% | N/A | N/A | N/A 34.68% | -0.81 -292.16% | -1.90 -134.57% | -2.32 -22.11% | -1.45 37.50% | N/A -35.77% | N/A 36.79% | N/A 837.70% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 34.13% | -0.36 | -0.30 -34.45% | -0.29 6.67% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.32M 33.62% | -18.87M 58.43% | -18.87M -59.11% | -18.87M -39.24% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
FILANA THERAPEUTICS INC / FLNA Forecast FAQ
Can you provide the consensus estimates for FILANA THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of FILANA THERAPEUTICS INC (FLNA) is -0.32 USD and the consensus revenue estimate is 0 USD.
How many analysts cover FILANA THERAPEUTICS INC (FLNA) stock?
The number of analysts covering FILANA THERAPEUTICS INC (FLNA) is 7.